Skip to main content

Imran Rizvi, PhD, is a UNC Lineberger Comprehensive Cancer Center member researching imaging and therapeutic applications of light, bioengineered 3D models and animal models for cancer, and targeted drug delivery for inhibition of molecular survival pathways in tumors.

PhD
Assistant Professor, Joint Department of Biomedical Engineering
UNC-Chapel Hill
Molecular Therapeutics

Area of Interest

Imran Rizvi, PhD, researches imaging and therapeutic applications of light, bioengineered 3D models and animal models for cancer, and targeted drug delivery for inhibition of molecular survival pathways in tumors. His K99/R00 (NCI) develops photodynamic therapy (PDT)-based combinations against molecular pathways that are altered by fluidic stress in ovarian cancer. He was also co-PI on an Innovation Award with Bristol-Myers Squibb to develop optical techniques in immuno-oncology for light-based modulation of immune response. He has co-authored 40 peer-reviewed publications and 5 book chapters with a focus on PDT, biomedical optics, and molecular targeting in cancer.

Find publications on PubMed